XOM vs CVX: side-by-side analysis

Where XOM and CVX sit on fair value

XOM's composite fair-value range is $113–$175 (midpoint $139), versus a current price of $145. CVX is one of XOM's closest sector neighbours and shows up directly in the peer table inside our full report, with a market-cap of $360.8B, P/E of 15.2x, EV/EBITDA of 10.9x, and an operating margin of 7.4%. The cross-read is editorial: same archetype expectations, same discount-rate philosophy, different operating model.

Both names are evaluated under the same six-factor decision overlay (customer value, unit economics, TAM, moat durability, risk profile, valuation) so comparing them is apples-to-apples rather than headline-multiple-to-headline-multiple. The rating differential between XOM and CVX is driven by where each lands across those six axes, not by who looks "cheaper" on a single screen.

Where they actually differ

XOM is classified as a cyclical stock; the archetype dictates our deceleration curve, terminal multiple, and probability weights. CVX, depending on its own archetype, will have its own calibration — and that is precisely why simple peer multiples can mislead. A 14.2× forward P/E with a PEG of 3.55 is not the same on XOM as it is on CVX unless they share the same growth profile, capital intensity, and moat half-life.

XOM's moat assessment is 6.5/10, and the full moat section in the report covers the source (network effects, switching costs, intangibles, scale, etc.) plus the timeline of any threats. The cross-read against CVX should focus on which company's economic profit (ROIC minus WACC) is wider AND more durable — that is the variable that dominates long-run total return between two same-sector names.

Which one wins on each dimension

Valuation: XOM trades close to fair value versus our fair-value midpoint. The full report's peer table compares XOM and CVX directly on P/E, PEG, EV/EBITDA, ROE, and operating margin. Risk: the bear case for XOM is bound by the kill-scenarios list in Section 2; the equivalent for CVX would need its own report. We do not co-rate two companies on a single page.

Capital allocation and growth runway typically separate same-sector pairs more than the headline numbers suggest. The full report's capital-allocation paragraph and TAM analysis are the lenses we recommend before deciding whether XOM or CVX is the better expression of the same theme.

Bottom line — XOM or CVX?

Our rating for XOM is Hold with a 81/100 confidence score; the rating already accounts for the relative-value information embedded in the peer table that includes CVX. The cross-read is most useful when the two companies are real substitutes in a portfolio (same factor exposure, same end markets, same archetype) — otherwise the comparison is theatre.

For the full evidence on XOM, including the explicit peer multiples versus CVX and the rest of the comp set, see the canonical report at /stocks/xom/analysis. For CVX's standalone report, see /stocks/cvx/analysis.

Frequently asked questions